Dr. Muhammad Shabbir S. Rawala, MD

Dr. Rawala practices at Houston Methodist West Hospital in Houston, Texas, part of Houston Methodist.

Dr. Rawala's NPI, 1194166504, was assigned on July 13, 2013. Dr. Rawala graduated from Dow University of Health Sciences in 2009. Dr. Rawala holds Texas license S5749.

Dr. Rawala's primary practice is Houston Methodist West Hospital, at 18500 Katy Freeway, Houston, TX 77094 in Harris County. The practice phone is (832) 522-1000.

Dr. Rawala's primary practice is Houston Methodist West Hospital in Houston, Texas, part of Houston Methodist. Dr. Rawala is also affiliated with Memorial Hermann Greater Heights Hospital. The medical group on file is Houston Methodist. Dmand AI also links Dr. Rawala to 4 more hospitals, 11 medical groups and 3 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rawala practices, 9 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Rawala's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Rawala is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Rawala's licenses on file in 4 states: Texas, Louisiana, West Virginia and North Carolina.

Dmand AI lists acute respiratory failure, anemia, chronic kidney disease, congestive heart failure, gastrointestinal obstruction, kidney failure, pneumonia and respiratory infection and sepsis among the conditions Dr. Rawala treats.

CMS data shows 5,094 Medicare services from Dr. Rawala across 19 procedure codes in 2024, for 415 Medicare patients. Medicare paid $202,426 for them.

CMS counts 415 Medicare patients who saw Dr. Rawala in 2024. The largest group is 65 to 74, with 132 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 22% are also on Medicaid. Their average risk score is 5.35, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rawala's median patient age at 67, with 48% women.

In 2024, Dr. Rawala wrote 258 Medicare Part D claims for 88 patients. 82% of them were for generic drugs. CMS names the drug for 122 of them, across 6 drugs with 11 or more claims each, at $17,449 in total drug cost. In 2022, CMS named 42 claims across 3 drugs.

Dr. Rawala accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 23 papers to Dr. Rawala, published from 2018 to 2020. 2019 was the busiest year, with 10. Dr. Rawala has published most often in Cureus. Dr. Rawala's most frequent co-authors are Kristen P. Helmick, MD, Muhammad Yasin, MD and Danish P. Abbasi, MD.

CMS Open Payments shows 63 general payments to Dr. Rawala from 14 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 58% of the total. Medtronic, Inc. paid the most, $3,285.

Dr. Rawala graduated from Dow University of Health Sciences in 2009.

Dr. Rawala is in network with 24 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.